Please login to the form below

Not currently logged in
Email:
Password:

Scott Gottlieb

This page shows the latest Scott Gottlieb news and features for those working in and with pharma, biotech and healthcare.

FDA takes aim at pharma’s biosimilar-delaying tactics

FDA takes aim at pharma’s biosimilar-delaying tactics

Ever-rising cost of insulins also to be targeted. FDA Commissioner Scott Gottlieb has repeated a warning that the agency will crack down on delaying tactics deployed by pharma to ... FDA Commissioner Scott Gottlieb. “ While the limited distribution

Latest news

More from news
Approximately 2 fully matching, plus 29 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Jet Off with Maloff Protect

Latest intelligence

AstraZeneca’s oncology renaissance
Susan Galbraith played a key role in restoring AstraZeneca’s place in cancer drug development – she talks about the future of oncology and why there’s more to be done to...
Navigating the antibiotic resistance crisis
Blue Latitude Health speaks to Tara DeBoer, PhD, Postdoctoral Researcher and CEO of BioAmp Diagnostics to explore the antimicrobial resistance crisis, and learn how a simple tool could support physicians...
Combined immunotherapies – potential and pitfalls
‘Combining therapeutic compounds is the first logical step towards better results, namely higher rates of patients responding to treatment, with deeper and more sustained responses’...

Infographics